Pharmacological profiling of Orthochirus scrobiculosus toxin 1 analogs with a trimmed N-terminal domain

Stéphanie Mouhat, Georgeta Teodorescu, Daniel Homerick, Violeta Visan, Heike Wulff, Yingliang Wu, Stephan Grissmer, Hervé Darbon, Michel De Waard, Jean Marc Sabatier

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

OSK1, a toxin from the venom of the Asian scorpion Orthochirus scrobiculosus, is a 38-residue peptide cross-linked by three disulfide bridges. A structural analog of OSK1, [Lys16,Asp20]-OSK1, was found previously to be one of the most potent blockers of the voltage-gated K + channel Kv1.3 hitherto characterized. Here, we demonstrate that progressive trimming of the N-terminal domain of [Lys16,Asp 20]-OSK1 results in marked changes in its pharmacological profile, in terms of both K+ channel affinity and selectivity. Whereas the affinity to Kv1.1 and Kv1.3 did not change significantly, the affinity to Kv1.2 and KCa3.1 was drastically reduced with the truncations. It is surprising that a striking gain in potency was observed for Kv3.2. In contrast, a truncation of the C-terminal domain, expected to partially disrupt the toxin β-sheet structure, resulted in a significant decrease or a complete loss of activity on all channel types tested. These data highlight the value of structure-function studies on the extended N-terminal domain of [Lys 16,Asp20]-OSK1 to identify new analogs with unique pharmacological properties.

Original languageEnglish (US)
Pages (from-to)354-362
Number of pages9
JournalMolecular Pharmacology
Volume69
Issue number1
DOIs
StatePublished - Jan 2006

Fingerprint

Pharmacology
Scorpion Venoms
Voltage-Gated Potassium Channels
Disulfides
Peptides

ASJC Scopus subject areas

  • Pharmacology

Cite this

Pharmacological profiling of Orthochirus scrobiculosus toxin 1 analogs with a trimmed N-terminal domain. / Mouhat, Stéphanie; Teodorescu, Georgeta; Homerick, Daniel; Visan, Violeta; Wulff, Heike; Wu, Yingliang; Grissmer, Stephan; Darbon, Hervé; De Waard, Michel; Sabatier, Jean Marc.

In: Molecular Pharmacology, Vol. 69, No. 1, 01.2006, p. 354-362.

Research output: Contribution to journalArticle

Mouhat, S, Teodorescu, G, Homerick, D, Visan, V, Wulff, H, Wu, Y, Grissmer, S, Darbon, H, De Waard, M & Sabatier, JM 2006, 'Pharmacological profiling of Orthochirus scrobiculosus toxin 1 analogs with a trimmed N-terminal domain', Molecular Pharmacology, vol. 69, no. 1, pp. 354-362. https://doi.org/10.1124/mol.105.017210
Mouhat, Stéphanie ; Teodorescu, Georgeta ; Homerick, Daniel ; Visan, Violeta ; Wulff, Heike ; Wu, Yingliang ; Grissmer, Stephan ; Darbon, Hervé ; De Waard, Michel ; Sabatier, Jean Marc. / Pharmacological profiling of Orthochirus scrobiculosus toxin 1 analogs with a trimmed N-terminal domain. In: Molecular Pharmacology. 2006 ; Vol. 69, No. 1. pp. 354-362.
@article{1c33b196d1a643398f65102fc3da5132,
title = "Pharmacological profiling of Orthochirus scrobiculosus toxin 1 analogs with a trimmed N-terminal domain",
abstract = "OSK1, a toxin from the venom of the Asian scorpion Orthochirus scrobiculosus, is a 38-residue peptide cross-linked by three disulfide bridges. A structural analog of OSK1, [Lys16,Asp20]-OSK1, was found previously to be one of the most potent blockers of the voltage-gated K + channel Kv1.3 hitherto characterized. Here, we demonstrate that progressive trimming of the N-terminal domain of [Lys16,Asp 20]-OSK1 results in marked changes in its pharmacological profile, in terms of both K+ channel affinity and selectivity. Whereas the affinity to Kv1.1 and Kv1.3 did not change significantly, the affinity to Kv1.2 and KCa3.1 was drastically reduced with the truncations. It is surprising that a striking gain in potency was observed for Kv3.2. In contrast, a truncation of the C-terminal domain, expected to partially disrupt the toxin β-sheet structure, resulted in a significant decrease or a complete loss of activity on all channel types tested. These data highlight the value of structure-function studies on the extended N-terminal domain of [Lys 16,Asp20]-OSK1 to identify new analogs with unique pharmacological properties.",
author = "St{\'e}phanie Mouhat and Georgeta Teodorescu and Daniel Homerick and Violeta Visan and Heike Wulff and Yingliang Wu and Stephan Grissmer and Herv{\'e} Darbon and {De Waard}, Michel and Sabatier, {Jean Marc}",
year = "2006",
month = "1",
doi = "10.1124/mol.105.017210",
language = "English (US)",
volume = "69",
pages = "354--362",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - Pharmacological profiling of Orthochirus scrobiculosus toxin 1 analogs with a trimmed N-terminal domain

AU - Mouhat, Stéphanie

AU - Teodorescu, Georgeta

AU - Homerick, Daniel

AU - Visan, Violeta

AU - Wulff, Heike

AU - Wu, Yingliang

AU - Grissmer, Stephan

AU - Darbon, Hervé

AU - De Waard, Michel

AU - Sabatier, Jean Marc

PY - 2006/1

Y1 - 2006/1

N2 - OSK1, a toxin from the venom of the Asian scorpion Orthochirus scrobiculosus, is a 38-residue peptide cross-linked by three disulfide bridges. A structural analog of OSK1, [Lys16,Asp20]-OSK1, was found previously to be one of the most potent blockers of the voltage-gated K + channel Kv1.3 hitherto characterized. Here, we demonstrate that progressive trimming of the N-terminal domain of [Lys16,Asp 20]-OSK1 results in marked changes in its pharmacological profile, in terms of both K+ channel affinity and selectivity. Whereas the affinity to Kv1.1 and Kv1.3 did not change significantly, the affinity to Kv1.2 and KCa3.1 was drastically reduced with the truncations. It is surprising that a striking gain in potency was observed for Kv3.2. In contrast, a truncation of the C-terminal domain, expected to partially disrupt the toxin β-sheet structure, resulted in a significant decrease or a complete loss of activity on all channel types tested. These data highlight the value of structure-function studies on the extended N-terminal domain of [Lys 16,Asp20]-OSK1 to identify new analogs with unique pharmacological properties.

AB - OSK1, a toxin from the venom of the Asian scorpion Orthochirus scrobiculosus, is a 38-residue peptide cross-linked by three disulfide bridges. A structural analog of OSK1, [Lys16,Asp20]-OSK1, was found previously to be one of the most potent blockers of the voltage-gated K + channel Kv1.3 hitherto characterized. Here, we demonstrate that progressive trimming of the N-terminal domain of [Lys16,Asp 20]-OSK1 results in marked changes in its pharmacological profile, in terms of both K+ channel affinity and selectivity. Whereas the affinity to Kv1.1 and Kv1.3 did not change significantly, the affinity to Kv1.2 and KCa3.1 was drastically reduced with the truncations. It is surprising that a striking gain in potency was observed for Kv3.2. In contrast, a truncation of the C-terminal domain, expected to partially disrupt the toxin β-sheet structure, resulted in a significant decrease or a complete loss of activity on all channel types tested. These data highlight the value of structure-function studies on the extended N-terminal domain of [Lys 16,Asp20]-OSK1 to identify new analogs with unique pharmacological properties.

UR - http://www.scopus.com/inward/record.url?scp=30044444119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=30044444119&partnerID=8YFLogxK

U2 - 10.1124/mol.105.017210

DO - 10.1124/mol.105.017210

M3 - Article

VL - 69

SP - 354

EP - 362

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 1

ER -